Literature DB >> 16357615

Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis.

Rita M Ramalho1, Helena Cortez-Pinto, Rui E Castro, Susana Solá, Adília Costa, Miguel C Moura, Maria E Camilo, Cecília M P Rodrigues.   

Abstract

OBJECTIVES: Apoptosis may play a role in the pathogenesis of alcoholic (ASH) and non-alcoholic steatohepatitis (NASH). In this study, we investigated the modulation of apoptosis-related liver proteins in steatohepatitis.
METHODS: Hepatocyte apoptosis was evaluated by the TUNEL assay in liver tissue of 12 patients with NASH, 12 with ASH and in histologically normal controls. In addition, caspase-3 processing was evaluated by immunoblot analysis. Expression of death receptors, Bcl-2 family members, and NF-kappaB inhibitor (IkappaB) were determined by western blot. Liver biopsies were also graded for inflammation and fibrosis.
RESULTS: Apoptotic hepatocytes were markedly increased in NASH (P<0.05) and ASH (P<0.001) as compared to controls. Active caspase-3 was also elevated in steatohepatitis (P<0.01), coinciding with upregulation of pro-apoptotic Bax (P<0.001). Further, production of tumour necrosis factor-receptor 1 was increased up to 4-fold (P<0.05). Degradation of IkappaB increased >70% in steatohepatitis (P<0.001). Notably, Bcl-2 was also strongly expressed (>100-fold; P<0.001). These data were significantly correlated with relative degrees of portal and lobular inflammation.
CONCLUSION: The results show that liver injury in NASH and ASH is associated with apoptosis and NF-kappaB activation. Anti-apoptotic Bcl-2 is strongly expressed, probably reflecting an adaptive response to obesity or alcohol-related stress.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16357615     DOI: 10.1097/00042737-200601000-00005

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  21 in total

1.  Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells.

Authors:  Wei Cui; Stephen L Chen; Ke-Qin Hu
Journal:  Am J Transl Res       Date:  2010-01-01       Impact factor: 4.060

2.  microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis.

Authors:  Timea Csak; Shashi Bala; Dora Lippai; Abishek Satishchandran; Donna Catalano; Karen Kodys; Gyongyi Szabo
Journal:  Liver Int       Date:  2014-07-28       Impact factor: 5.828

Review 3.  Non-alcoholic fatty liver disease: what the clinician needs to know.

Authors:  Mariana Verdelho Machado; Helena Cortez-Pinto
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 4.  Alcoholic liver disease: pathogenesis and new targets for therapy.

Authors:  José Altamirano; Ramón Bataller
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-08-09       Impact factor: 46.802

5.  Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease.

Authors:  D M S Ferreira; R E Castro; M V Machado; T Evangelista; A Silvestre; A Costa; J Coutinho; F Carepa; H Cortez-Pinto; C M P Rodrigues
Journal:  Diabetologia       Date:  2011-04-01       Impact factor: 10.122

Review 6.  New treatment options for alcoholic hepatitis.

Authors:  Saggere Muralikrishna Shasthry; Shiv Kumar Sarin
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742

7.  Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells.

Authors:  Li-Jun Yu; Mo-Li Wu; Hong Li; Xiao-Yan Chen; Qian Wang; Yuan Sun; Qing-You Kong; Jia Liu
Journal:  Neoplasia       Date:  2008-07       Impact factor: 5.715

8.  A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

Authors:  Zobair M Younossi; Mohammed Jarrar; Clare Nugent; Manpreet Randhawa; Mariam Afendy; Maria Stepanova; Nila Rafiq; Zachary Goodman; Vikas Chandhoke; Ancha Baranova
Journal:  Obes Surg       Date:  2008-05-24       Impact factor: 4.129

9.  Increased expression of c-Jun in nonalcoholic fatty liver disease.

Authors:  Christoph Dorn; Julia C Engelmann; Michael Saugspier; Andreas Koch; Arndt Hartmann; Martina Müller; Rainer Spang; Anja Bosserhoff; Claus Hellerbrand
Journal:  Lab Invest       Date:  2014-02-03       Impact factor: 5.662

10.  Zinc supplementation inhibits hepatic apoptosis in mice subjected to a long-term ethanol exposure.

Authors:  Zhanxiang Zhou; Jie Liu; Zhenyuan Song; Craig J McClain; Y James Kang
Journal:  Exp Biol Med (Maywood)       Date:  2008-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.